Bariatrie: Revisionseingriffe bei Therapieversagen und Reflux

Die Chirurgie gewinnt im Rahmen der Adipositasbehandlung weiterhin an Bedeutung mit steigenden Zahlen. Sie verkörpert nicht nur die bislang effektivste Möglichkeit zur Gewichtsreduktion, sondern ist nachgewiesenermaßen auch eine sinnvolle Therapieoption zur Bekämpfung adipositasassoziierter Erkrankungen. Was aber tun, wenn die Chirurgie nicht den gewünschten Effekt bringt oder sogar durch beispielsweise Reflux die Lebensqualität von Patient*innen einschränkt?

• Literatur

• 1 Wendy A, Brown RL, Holland J. et al. Seventh IFSO Global Registry Report 2022. The International Federation for the Surgery of Obesity and Metabolic Disorders; 2022
• 2 Salminen P, Gronroos S, Helmio M. et al. Effect of laparoscopic sleeve gastrectomy vs. Roux-en-Y Gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA Surg 2022; 157: 656-666
• 3 El Ansari W, Elhag W. Weight Regain and Insufficient weight loss after bariatric surgery: definitions, prevalence, mechanisms, predictors, prevention and management strategies, and knowledge gaps – scoping review. Obes Surg 2021; 31: 1755-1766
• 4 Athanasiadis DI, Martin A, Kapsampelis P. et al. Factors associated with weight regain post-bariatric surgery: a systematic review. Surg Endosc 2021; 35: 4069-4084
• 5 Rebelos E, Moriconi D, Honka MJ. et al. Decreased Weight loss following bariatric surgery in patients with type 2 diabetes. Obes Surg 2023; 33: 179-187
• 6 Finze A, Otto M, Reissfelder M. et al. Therapieoptionen bei Weight-Regain nach Bariatrischer Operation. Zentralbl Chir 2022; 147: 547-555
• 7 Karmali S, Brar B, Shi X. et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg 2013; 23: 1922-1933
• 8 Pi-Sunyer X, Astrup A, Fujioka K. et al. A Randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med 2015; 373: 11-22
• 9 DGAV (Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie) et al.. S3-Leitlinie Chirurgie der Adipositas und metabolischer Erkrankungen. AWMF Leitlinien. Registernummer 088-001. 2018: 35-46
• 10 Wilding JPH, Batterham RL, Calanna S. et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 2021; 384: 989-1002
• 11 Yeo C, Ho G, Syn N. et al. Revisional One-anastomosis gastric bypass after restrictive index surgery-a metaanalysis and comparison with revisional Roux-en-Y Gastric bypass. Obes Surg 2021; 31: 949-964
• 12 Boerboom A, Homan J, Aarts E. et al. A long biliopancreatic and short alimentary limb results in more weight loss in revisional RYGB surgery. Outcomes of the randomized controlled ELEGANCE REDO trial. Surg Obes Relat Dis 2019; 15: 60-69
• 13 Franken RJ, Sluiter NR, Franken J. et al. Treatment options for weight regain or insufficient weight loss after sleeve gastrectomy: a systematic review and meta-analysis. Obes Surg 2022; 32: 2035-2046
• 14 Gentileschi P, Bianciardi E, Siragusa L. et al. Banded sleeve gastrectomy improves weight loss compared to nonbanded sleeve: midterm results from a prospective randomized study. J Obes 2020; 2020: 9792518
• 15 Ghiassi S, Higa K, Chang S. et al. Conversion of standard Roux-en-Y gastric bypass to distal bypass for weight loss failure and metabolic syndrome: 3-year follow-up and evolution of technique to reduce nutritional complications. Surg Obes Relat Dis 2018; 14: 554-561
• 16 Gadiot RPM, Biter LU, Feskens PG. et al. Midterm results from the dutch common channel trial (ducati): superior weight loss results of the long roux limb gastric bypass in comparison to the standard bypass at 3-year follow-up. Obes Surg 2021; 31: 5132-5140
• 17 Peterli R, Wolnerhanssen BK, Peters T. et al. Effect of laparoscopic sleeve gastrectomy vs. laparoscopic roux-en-y gastric bypass on weight loss in patients with morbid obesity: the sm-boss randomized clinical trial. JAMA 2018; 319: 255-265
• 18 Kassir R, Petrucciani N, Debs T. et al. Conversion of one anastomosis gastric bypass (oagb) to roux-en-y gastric bypass (rygb) for biliary reflux resistant to medical treatment: lessons learned from a retrospective series of 2780 consecutive patients undergoing OAGB. Obes Surg 2020; 30: 2093-2098
• 19 Khalaf M, Hamed H. Single-anastomosis sleeve ileal (sasi) bypass: hopes and concerns after a two-year follow-up. Obes Surg 2021; 31: 667-674
• 20 Genta RM, Spechler SJ, Kielhorn KF. The Los Angeles and Savary-Miller systems for grading esophagitis: utilization and correlation with histology. Dis Esophag 2011; 24: 10-17
• 21 Guzman-Pruneda FA, Brethauer SA. Gastroesophageal reflux after sleeve gastrectomy. J Gastrointest Surg 2021; 25: 542-550
• 22 Werapitiya SB, Ruwanpura SP, Coulson TR. Laparoscopic fundoplication using the excluded stomach as a novel management option for refractory bile reflux following one anastomosis gastric bypass (OAGB). Obes Surg 2022; 32: 561-566